Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 437

Similar articles for PubMed (Select 17563058)

1.

Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.

Skov V, Glintborg D, Knudsen S, Jensen T, Kruse TA, Tan Q, Brusgaard K, Beck-Nielsen H, Højlund K.

Diabetes. 2007 Sep;56(9):2349-55. Epub 2007 Jun 11.

2.

Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome.

Skov V, Glintborg D, Knudsen S, Tan Q, Jensen T, Kruse TA, Beck-Nielsen H, Højlund K.

PLoS One. 2008 Jun 18;3(6):e2466. doi: 10.1371/journal.pone.0002466.

3.

Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.

Højlund K, Glintborg D, Andersen NR, Birk JB, Treebak JT, Frøsig C, Beck-Nielsen H, Wojtaszewski JF.

Diabetes. 2008 Feb;57(2):357-66. Epub 2007 Oct 31.

4.

Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes.

Frederiksen CM, Højlund K, Hansen L, Oakeley EJ, Hemmings B, Abdallah BM, Brusgaard K, Beck-Nielsen H, Gaster M.

Diabetologia. 2008 Nov;51(11):2068-77. doi: 10.1007/s00125-008-1122-9. Epub 2008 Aug 22.

PMID:
18719883
6.

[Genetic aspects of polycystic ovary syndrome].

Jakubowski L.

Endokrynol Pol. 2005 May-Jun;56(3):285-93. Review. Polish.

PMID:
16350721
7.

Impaired mitochondrial oxidative phosphorylation in multiple insulin-sensitive tissues of humans with type 2 diabetes mellitus.

Wang M, Wang XC, Zhang ZY, Mou B, Hu RM.

J Int Med Res. 2010 May-Jun;38(3):769-81.

PMID:
20819414
8.

Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose.

Tan BK, Adya R, Farhatullah S, Lewandowski KC, O'Hare P, Lehnert H, Randeva HS.

Diabetes. 2008 Apr;57(4):801-8. doi: 10.2337/db07-0990. Epub 2008 Jan 3.

9.

Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation.

Crunkhorn S, Dearie F, Mantzoros C, Gami H, da Silva WS, Espinoza D, Faucette R, Barry K, Bianco AC, Patti ME.

J Biol Chem. 2007 May 25;282(21):15439-50. Epub 2007 Apr 6.

10.

Type 2 diabetes and the polycystic ovary syndrome.

Pelusi B, Gambineri A, Pasquali R.

Minerva Ginecol. 2004 Feb;56(1):41-51. Review.

PMID:
14973409
11.
12.

Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome.

Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Tapanainen JS.

Hum Reprod. 2000 Jun;15(6):1266-74.

13.

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.

Yilmaz M, Ergün MA, Karakoç A, Yurtçu E, Yetkin I, Ayvaz G, Cakir N, Arslan M.

Gynecol Endocrinol. 2005 Oct;21(4):206-10.

PMID:
16316841
14.

Gene expression in humans with diabetes and prediabetes: what have we learned about diabetes pathophysiology?

Patti ME.

Curr Opin Clin Nutr Metab Care. 2004 Jul;7(4):383-90. Review.

PMID:
15192439
15.

Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients.

Debard C, Laville M, Berbe V, Loizon E, Guillet C, Morio-Liondore B, Boirie Y, Vidal H.

Diabetologia. 2004 May;47(5):917-25. Epub 2004 May 1.

PMID:
15127202
16.

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS).

Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E.

Am J Physiol Endocrinol Metab. 2001 Aug;281(2):E392-9.

17.

Expression profiling following local muscle inactivity in humans provides new perspective on diabetes-related genes.

Timmons JA, Norrbom J, Schéele C, Thonberg H, Wahlestedt C, Tesch P.

Genomics. 2006 Jan;87(1):165-72. Epub 2005 Dec 2.

18.

Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients.

Takamura T, Misu H, Matsuzawa-Nagata N, Sakurai M, Ota T, Shimizu A, Kurita S, Takeshita Y, Ando H, Honda M, Kaneko S.

Obesity (Silver Spring). 2008 Dec;16(12):2601-9. doi: 10.1038/oby.2008.419. Epub 2008 Oct 9.

PMID:
18846047
19.

Genes involved in oxidative phosphorylation are coordinately upregulated with fasting hyperglycaemia in livers of patients with type 2 diabetes.

Misu H, Takamura T, Matsuzawa N, Shimizu A, Ota T, Sakurai M, Ando H, Arai K, Yamashita T, Honda M, Yamashita T, Kaneko S.

Diabetologia. 2007 Feb;50(2):268-77. Epub 2006 Dec 23.

PMID:
17187250
20.

A PGC-1α- and muscle fibre type-related decrease in markers of mitochondrial oxidative metabolism in skeletal muscle of humans with inherited insulin resistance.

Kristensen JM, Skov V, Petersson SJ, Ørtenblad N, Wojtaszewski JF, Beck-Nielsen H, Højlund K.

Diabetologia. 2014 May;57(5):1006-15. doi: 10.1007/s00125-014-3187-y. Epub 2014 Feb 9.

PMID:
24510228
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk